Email this article 
Hide
Show all
Guideline
Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update
Southern African Journal of HIV Medicine | Vol 20, No 1 | a1030 |
DOI: https://doi.org/10.4102/sajhivmed.v20i1.1030
| © 2019 Nelesh Govender
| This work is licensed under CC Attribution 4.0
Submitted: 05 September 2019 | Published: 08 November 2019
Submitted: 05 September 2019 | Published: 08 November 2019
About the author(s)
Nelesh P. Govender, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa; and, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa; and, Division of Medical Microbiology, University of Cape Town, Cape Town, South AfricaGraeme Meintjes, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; and, Department of Medicine, University of Cape Town, Cape Town, South Africa
Phetho Mangena, Polokwane Hospital, Polokwane, South Africa
Jeremy Nel, Helen Joseph Hospital, University of the Witwatersrand, Johannesburg, South Africa
Samantha Potgieter, Department of Internal Medicine, University of the Free State, Bloemfontein, South Africa
Denasha Reddy, Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
Helena Rabie, Department of Paediatrics, Tygerberg Hospital, Stellenbosch University, Stellenbosch, South Africa
Douglas Wilson, Department of Internal Medicine, Edendale Hospital, Pietermaritzburg, South Africa; and, School of Clinical Medicine, University of KwaZulu-Natal, Pietermaritzburg, South Africa
John Black, Department of Infectious Diseases, Livingstone Hospital, Port Elizabeth, South Africa
David Boulware, Department of Medicine, Centre for Infectious Diseases and Microbiology Translational Research, University of Minnesota, Minneapolis, United States
Tom Boyles, Anova Health Institute, Johannesburg, South Africa; and, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Tom Chiller, Mycotic Diseases Branch, US Centres for Disease Control and Prevention, Atlanta, United States
Halima Dawood, Department of Medicine, Grey’s Hospital, Pietermaritzburg, South Africa; and, Caprisa, University of KwaZulu-Natal, Pietermaritzburg, South Africa
Sipho Dlamini, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
Thomas S. Harrison, Centre for Global Health, Institute of Infection and Immunity, St George’s University of London, London, United Kingdom
Prudence Ive, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; and, Division of Infectious Diseases, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, Helen Joseph Hospital, Johannesburg, South Africa
Joseph Jarvis, Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
Alan Karstaedt, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; and, Division of Infectious Diseases, Department of Internal Medicine, Charlotte Maxeke Johannesburg Hospital, Johannesburg, South Africa
Matamela C. Madua, Department of Medicine, Rob Ferreira Hospital, Mbombela, South Africa
Colin Menezes, Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa; and, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Mahomed-Yunus S. Moosa, Department of Infectious Diseases, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
Zaaheera Motlekar, Department of Medicine, Kimberley Provincial Hospital, Kimberley, South Africa
Amir Shroufi, Mycotic Diseases Branch, US Centres for Disease Control and Prevention, Atlanta, South Africa
Sarah L. Stacey, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; and, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa
Merika Tsitsi, Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa; and, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Gilles van Cutsem, Southern Africa Medical Unit, Médecins Sans Frontières, Cape Town, South Africa; and, Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa
Ebrahim Variava, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; and, Department of Medicine, Tshepong Hospital, Klerksdorp, South Africa
Michelle Venter, Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa; and, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Rachel Wake, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa; and, Centre for Global Health, Institute of Infection and Immunity, St George’s University of London, London, United Kingdom
Abstract
No abstract available.
Keywords
No related keywords in the metadata.
Metrics
Total abstract views: 31452Total article views: 19668